Akoya BioSciences, Inc. (AKYA) Financials
AKYA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 180.4 million | 126.6 million |
2023-09-30 | 177.2 million | 115.3 million |
2023-06-30 | 188.9 million | 117.0 million |
2023-03-31 | 154.3 million | 112.2 million |
AKYA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -6.1 million | 2.6 million |
2023-09-30 | -14.6 million | 2.9 million |
2023-06-30 | -13.2 million | 2.6 million |
2023-03-31 | -20.6 million | 2.4 million |
AKYA Net Income
No data available :(
AKYA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 83.1 million | - | 10.5 million |
2023-09-30 | 78.6 million | - | 11.3 million |
2023-06-30 | 93.3 million | 63.6 million | 12.0 million |
2023-03-31 | 60.2 million | 63.5 million | 11.8 million |
AKYA Shares Outstanding
AKYA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 594000 | 4.7 million | 18.9 million | - |
2023-09-30 | 832000 | 5.2 million | 19.0 million | - |
2023-06-30 | 1.4 million | 6.3 million | 22.7 million | - |
2023-03-31 | 804000 | 5.8 million | 22.0 million | - |
AKYA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 26.5 million | 11.7 million |
2023-09-30 | 25.2 million | 9.9 million |
2023-06-30 | 23.5 million | 11.4 million |
2023-03-31 | 21.4 million | 9.1 million |
AKYA
Price: $4.04
52 week price:
Earnings Per Share: -1.43 USD
P/E Ratio: -3.46
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 51598
Market Capitalization: 203.0 million